POMALIDOMIDE PLUS LOW-DEXAMETHASONE TREATMENT FOR ≥ 1 YEAR IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: A SUBANALYSIS OF THE MM-013 PHASE 2 STUDY
Weisel, K., Dimopoulos, M., Cook, M., Ramasamy, K., de La Rubia, J., Ardizzoia, A., Krauth, M. T., Jaccard, A., Van de Donk, N., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P.Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000566952.01531.20
Date:
June, 2019
File:
PDF, 463 KB
2019